Veracyte (VCYT) Operating Leases (2019 - 2026)

Veracyte has disclosed Operating Leases across 8 years of filings, most recently posting $40.1 million for Q2 2026.

• In Q2 2026, Operating Leases fell 20.81% year-over-year to $40.1 million; the TTM figure through Jun 2026 stood at $40.1 million (down 20.81% YoY), while the FY2025 annual figure was $35.6 million, down 17.66% from the prior year.
• Operating Leases came in at $40.1 million for Q2 2026 at Veracyte, up from $39.3 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $50.6 million in Q2 2025 to a low of $7.5 million in Q4 2023.
• Average Operating Leases over 5 years is $25.8 million, with a median of $18.5 million recorded in 2022.
• Year-over-year, Operating Leases retreated 29.33% in 2023 and soared 474.58% in 2024.
• Over 5 years, Operating Leases stood at $10.6 million in 2022, then dropped by 29.33% to $7.5 million in 2023, then soared by 474.58% to $43.2 million in 2024, then fell by 17.66% to $35.6 million in 2025, then grew by 12.65% to $40.1 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $40.1 million in Q2 2026, $39.3 million in Q1 2026, and $35.6 million in Q4 2025.